These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9292959)

  • 21. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance.
    Fatourechi V; Hay ID
    Semin Nucl Med; 2000 Apr; 30(2):107-14. PubMed ID: 10787191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 131I therapy for elevated thyroglobulin levels.
    Schlumberger M; Mancusi F; Baudin E; Pacini F
    Thyroid; 1997 Apr; 7(2):273-6. PubMed ID: 9133699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer.
    Vermiglio F; Violi MA; Finocchiaro MD; Baldari S; Castagna MG; Moleti M; Mattina F; Pio Lo Presti V; Bonanno N; Trimarchi F
    Thyroid; 1999 Apr; 9(4):387-91. PubMed ID: 10319946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenously labeled thyroid hormones (131I-T3/T4) in sera of patients with differentiated thyroid carcinoma.
    Lukinac L; Franceschi M; Nöthig-Hus D; Lechpammer S; Tomasić J; Vranesić B; Pape E; Kusić Z
    Thyroid; 1996 Jun; 6(3):201-6. PubMed ID: 8837327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?
    McDougall IR
    J Endocrinol Invest; 2001 Mar; 24(3):194-8. PubMed ID: 11314751
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of serum thyroglobulin measurements and whole body 131I scanning in the management of treated differentiated thyroid carcinoma.
    Galligan JP; Winship J; van Doorn T; Mortimer RH
    Aust N Z J Med; 1982 Aug; 12(4):248-54. PubMed ID: 6814409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy.
    de Klerk JM; de Keizer B; Zelissen PM; Lips CM; Koppeschaar HP
    Nucl Med Commun; 2000 Jun; 21(6):529-32. PubMed ID: 10894561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
    Ozata M; Suzuki S; Miyamoto T; Liu RT; Fierro-Renoy F; DeGroot LJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):98-105. PubMed ID: 8027262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases.
    Kabasakal L; Selçuk NA; Shafipour H; Ozmen O; Onsel C; Uslu I
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1500-4. PubMed ID: 15232654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a diagnostic dose of 185 MBq 131I on postsurgical thyroid remnants.
    Bajén MT; Mañé S; Muñoz A; García JR
    J Nucl Med; 2000 Dec; 41(12):2038-42. PubMed ID: 11138690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy.
    Taïeb D; Lussato D; Guedj E; Roux F; Mundler O
    Thyroid; 2006 Feb; 16(2):177-9. PubMed ID: 16676403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.
    Pacini F; Lippi F; Formica N; Elisei R; Anelli S; Ceccarelli C; Pinchera A
    J Nucl Med; 1987 Dec; 28(12):1888-91. PubMed ID: 3681445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer.
    Kloos RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1519-25. PubMed ID: 18463349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
    Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
    Ramanna L; Waxman A; Braunstein G
    J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of thyroglobulin changes for the efficacy of thyroid remnant ablation.
    Savelli G; Chiti A; Rodari M; Schreiner F; Maccauro M; Aliberti G; Gerali A; Bombardieri E
    Tumori; 2001; 87(1):42-6. PubMed ID: 11669557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.